Medical equipment

RedDress Receives FDA 510(k) Clearance for RD1 System

Retrieved on: 
Tuesday, July 10, 2018

PARDES-HANNA, Israel, July 10, 2018 /PRNewswire/ -- RedDress Ltd announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RD1 system.

Key Points: 
  • PARDES-HANNA, Israel, July 10, 2018 /PRNewswire/ -- RedDress Ltd announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RD1 system.
  • The RD1 System is intended to be used at point-of-care for the safe and rapid preparation of whole blood clot from a small sample of a patient's own peripheral blood.
  • The 510(k) clearance allows RedDress to introduce its innovative device technology to the U.S. market, where it will be marketed as the RD1 System for the indications for use cited above.
  • "The recent FDA clearance is a significant milestone for RedDress," said Alon Kushnir, Founder and CEO.

AMPLEXOR's 20th Annual BE THE EXPERT Event Focuses on Artificial Intelligence, Regulatory Information Management and Their Impact on Life Sciences

Retrieved on: 
Monday, July 9, 2018

A key of theme of BE THE EXPERT 2018 was artificial intelligence (AI) and its potential in Life Sciences.

Key Points: 
  • A key of theme of BE THE EXPERT 2018 was artificial intelligence (AI) and its potential in Life Sciences.
  • Regulatory Information Management (RIM) grows ever more important in life sciences and speakers from AMPLEXOR customers AbbVie and Alexion shared their own experiences of best practice RIM implementation.
  • AMPLEXOR Life Sciences assists organizationsdevelopingpharmaceuticals, medical devices, and biotechnology withlaunching products and breaking into new markets quickly.
  • It boasts a rich 25+ year history of serving pharmaceuticalproducers, medical device manufacturers, and biotechnology companies.

Global Strategic Outlook on the Stethoscopes Market 2018-2022 - Stethoscope Apps on Smartphones: The Way of the Future

Retrieved on: 
Monday, July 9, 2018

Rudolf Riester GmbH & Co. KG (Germany)

Key Points: 

Rudolf Riester GmbH & Co. KG (Germany)
Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. (China)
Demographics Statistics of Aging Populace: Unfurling the Market Potential
Hand-held Ultrasounds: A Threat to Conventional Stethoscopes?
HD Medical Establishes New Facility in Santa Clara, US

Airway Management Devices Market Worth 2.10 billion USD by 2023

Retrieved on: 
Monday, July 9, 2018

According to a new market research report "Airway Management Devices Market by Type (Supraglottic Device (LMA & Oropharyngeal Airway), Infraglottic Device (Tracheostomy Tube and ET Tube), Resuscitators, Laryngoscope), End User (OR & ICU), Patient Age (Adult and Pediatric) - Global Forecast to 2023", published by MarketsandMarkets, the global market is projected to reach USD 2.10 billion by 2023 from an estimated USD 1.60 billion in 2018, at a CAGR of 5.6% during the forecast period (2018-2023).

Key Points: 
  • According to a new market research report "Airway Management Devices Market by Type (Supraglottic Device (LMA & Oropharyngeal Airway), Infraglottic Device (Tracheostomy Tube and ET Tube), Resuscitators, Laryngoscope), End User (OR & ICU), Patient Age (Adult and Pediatric) - Global Forecast to 2023", published by MarketsandMarkets, the global market is projected to reach USD 2.10 billion by 2023 from an estimated USD 1.60 billion in 2018, at a CAGR of 5.6% during the forecast period (2018-2023).
  • Based on type, the Airway Management Devices Market is segmented into supraglottic airway management devices, infraglottic airway management devices, resuscitators, laryngoscopes, and other airway management devices such as stylets, bronchial blocking tubes, lumen tubes, and suction devices.
  • Based on patient age, the Airway Management Devices Market is segmented into adult patients and pediatric patients/neonates.
  • In 2018, North America is expected to account for the largest share of the Airway Management Devices Market, followed by Europe.

Prof. Thomas Binder of e-Learning Medical Education Platform 123Sonography Awarded Ars Docendi State Prize for Project "Echocardiography/Anatomy - Blended Learning"

Retrieved on: 
Monday, July 9, 2018

Limited resources and the complexity of the method make it difficult for students to exercise it in practice.

Key Points: 
  • Limited resources and the complexity of the method make it difficult for students to exercise it in practice.
  • The videos demonstrate the technique of ultrasound and its examination and impart basic anatomical knowledge using living donors and prepared heart models.
  • In this capacity Thomas Binder holds numerous courses and seminars at home and abroad and operates an e-learning platform for echocardiography ( http://www.123sonography.com ).
  • 123Sonography is the global #1 e-learning platform for medical ultrasound and echocardiography for medical professionals.

First FDA-Approved Handheld Ultrasound Device Expands The Use of Diagnostic Ultrasound Beyond Obstetrics in The US

Retrieved on: 
Monday, July 9, 2018

It provides flexible ultrasound technology at less than 1/10 the cost of a traditional ultrasound machine, with a user interface anyone can learn in minutes.

Key Points: 
  • It provides flexible ultrasound technology at less than 1/10 the cost of a traditional ultrasound machine, with a user interface anyone can learn in minutes.
  • says, "SONON 300L is smaller and easier to use than any other ultrasound technology in the US market.
  • SONON 300L is an advanced diagnostic imaging device that can be used anywhere, with an app downloaded from the Google Play or Apple App Store.
  • In other countries with world-class healthcare capabilities and outcomes, a larger percentage of physicians utilize diagnostic ultrasound in primary care.

Implantable Drug Delivery Devices Market Worth $31.6 Billion By 2025: Grand View Research, Inc.

Retrieved on: 
Monday, July 9, 2018

The global implantable drug delivery devices market size is expected to reach USD 31.6 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.5% CAGR during the forecast period.

Key Points: 
  • The global implantable drug delivery devices market size is expected to reach USD 31.6 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.5% CAGR during the forecast period.
  • Growing incidence of chronic diseases, coupled with rising demand for minimally invasive treatment options, is driving the market for implantable drug delivery devices.
  • Manufacturers are focused on developing novel drug delivery devices to gain maximum market share, which has resulted in launch of various technologically advanced products in the market.
  • Grand View Research has segmented the global implantable drug delivery devices market on the basis of product, type, technology, application, and region:
    Implantable Drug Delivery Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

Japan Medical Devices Market Overview & Outlook 2018-2022 - Growing Aging Population and Prevalence of Age-Related Disorders

Retrieved on: 
Friday, July 6, 2018

The medical devices market in Japan to generate revenue of close to USD 42 billion by 2022.

Key Points: 
  • The medical devices market in Japan to generate revenue of close to USD 42 billion by 2022.
  • Medical Devices Market in Japan 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts.
  • According to the report, one driver in the market is growing aging population and prevalence of age-related disorders.
  • Any device entering the Japanese market must undergo stringent safety examinations and demonstrate medical efficacy prior to approval or Shonin.

InventHelp Inventor Develops Assistive Device for Administering Medications (CCP-1390)

Retrieved on: 
Friday, July 6, 2018

He created a prototype the patent pending EASY DRAW, to hold a vial and syringe in a stable manner to prevent hand cramps and bending needles.

Key Points: 
  • He created a prototype the patent pending EASY DRAW, to hold a vial and syringe in a stable manner to prevent hand cramps and bending needles.
  • The unit locates the tip of the needle just inside the vial, to allow drawing the most medicine from the vial to aid cost savings.
  • The invention helps eliminate the syringe from slipping out of the vial and possibly causing an accidental stick.
  • It also allows for rotating the syringe to easily see the graduations for precise measurement of medication.

Pediatric Medical Devices Market to Become Worth US$ 41,000 Mn by 2026, Says TMR

Retrieved on: 
Friday, July 6, 2018

Transparency Market Research (TMR) has published a new report titled, "Pediatric Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026".

Key Points: 
  • Transparency Market Research (TMR) has published a new report titled, "Pediatric Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026".
  • According to the report, the global pediatric medical devices market was valued at US$ 21,000 Mn in 2017 and is projected to expand at a CAGR of 8.0% from 2018 to 2026.
  • The global pediatric medical devices market has been segmented based on product and end-user.
  • In terms of product, the global market has been categorized into in vitro diagnostic (IVD) devices, cardiology devices diagnostic imaging devices, anesthesia & respiratory care devices, neonatal ICU devices, monitoring devices, telemedicine, and home-use medical devices.